Advances in Therapeutic Development Across Modalities

Rapid Fire: Recent Advances in Gene Therapy

Rapid Fire Moderator(s)

• 

  Robert Dodge, PhD

  Global Lead, Biologics Bioanalysis
  Novartis Institutes for BioMedical Research, Inc.
  East Hanover, New Jersey, United States

Presentations:

• 2:30 PM – 2:45 PM ET

  Emerging Trends for Diagnostic Testing in Gene Therapies
  

  Rapid Fire Speaker: Jim Glick, PhD – Novartis Pharmaceutical Corp.
• 2:45 PM – 3:00 PM ET

  Considerations for Developing and Validating an Anti-AAV9 ADA Assay
  

  Rapid Fire Speaker: Sara Alhakeem, PhD – BioAgilytix
• 3:00 PM – 3:15 PM ET

  Novel Alternatives to ELISPOT Assay for AAV Gene Therapy Clinical Studies
  

  Rapid Fire Speaker: Ayuko Ota-Setlik, MS (she/her/hers) – Pfizer
• 3:15 PM – 3:30 PM ET

  qPCR Biodistribution and Shedding Assessment Strategy in Gene Therapy Studies
  

  Rapid Fire Speaker: Amanda L. Hays, Ph.D. – BioAgilytix Labs, LLC.